MHRA permits cell/gene therapy production at CGT Catapult site
The production of new cell and gene therapies at a manufacturing site in Stevenage – for use in health services around the world – has been given the green light by the Medicines and Healthcare products Regulatory Agency (MHRA).
Read More
